p53-slp
Biologicalexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2008 (NCT00844506)
Timeline
Indications
Studied for
Mechanism of action
- Cellular tumor antigen p53Immunity, active
TP53 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- p53-slp
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01639885 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2011 | Leiden University, University of Groningen |
| NCT00844506 | Phase 2 | Oct 1, 2008 | Dutch Cancer Society, ISA Pharmaceuticals, University of Groningen |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Groningen | Academic/Hospital | 2 | 1 | 1 | 2008 |
| Dutch Cancer Society | Academic/Hospital | 1 | 0 | 1 | 2008 |
| ISA Pharmaceuticals | For profit | 1 | 0 | 1 | 2008 |
| Leiden University | Academic/Hospital | 1 | 1 | 1 | 2011 |
4 organizations
Page 1 / 1